Applied DNA Sciences, Inc.

COMMUNIQUÉ DE PRESSE

publié le 18/03/2024 à 14:00, il y a 8 mois 5 jours

Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
Applied DNA Sciences and Alphazyme LLC collaborate to enhance manufacturing of Linea RNA polymerase to meet growing demand for Linea IVT platform. Project aims to increase RNAP manufacturing capacity and reduce unit costs

Manufacturing Applied DNA Sciences Linea IVT Platform Alphazyme LLC Linea RNA Polymerase
BRÈVE

publiée le 14/03/2024 à 15:05, il y a 8 mois 9 jours

Applied DNA présentera des plateformes ADN avancées au Congrès mondial du vaccin

Congrès Mondial Du Vaccin Sciences Appliquées De L'ADN Plateforme ADN Linea Plateforme Linea IVT Production D'ARNm
BRÈVE

publiée le 14/03/2024 à 15:05, il y a 8 mois 9 jours

Applied DNA to Present Advanced DNA Platforms at World Vaccine Congress

Applied DNA Sciences World Vaccine Congress Linea DNA Platform Linea IVT Platform MRNA Production
COMMUNIQUÉ DE PRESSE

publié le 14/03/2024 à 15:00, il y a 8 mois 9 jours

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress
Applied DNA Sciences, Inc. will showcase Linea™ IVT and Linea™ DNA platforms at the 24th Annual World Vaccine Congress in Washington, D.C. Sales team available

Applied DNA Sciences DNA Technologies World Vaccine Congress Linea DNA Linea IVT
COMMUNIQUÉ DE PRESSE

publié le 08/02/2024 à 22:05, il y a 9 mois 15 jours

Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc. (NASDAQ:APDN) announces Q1 fiscal year 2024 financial results and progress on GMP production capacity for mRNA therapeutics. Projects initial facility capacity to enable up to $15 million Linea IVT revenue annually

Financial Results Applied DNA Sciences MRNA Therapeutics GMP Production Capacity Linea IVT Revenue
COMMUNIQUÉ DE PRESSE

publié le 05/02/2024 à 19:00, il y a 9 mois 18 jours

Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
Applied DNA Sciences, Inc. will release first quarter fiscal 2024 financial results after market close on February 8, 2024, with a conference call for analysts. The company operates in biotechnology developing DNA detection and production technologies

Financial Results Conference Call Biotechnology Applied DNA Sciences DNA Detection
COMMUNIQUÉ DE PRESSE

publié le 02/02/2024 à 22:15, il y a 9 mois 21 jours

Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. closes registered direct offering of common stock priced at-the-market with institutional investors. Proceeds to be used for therapeutic DNA production services

Registered Direct Offering Institutional Investors Common Stock Applied DNA Sciences DNA Technologies
COMMUNIQUÉ DE PRESSE

publié le 31/01/2024 à 14:00, il y a 9 mois 23 jours

Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. announces a registered direct offering and a concurrent private placement to certain existing institutional investors. Maxim Group LLC acts as exclusive placement agent

Registered Direct Offering Applied DNA Sciences Securities Purchase Agreements Maxim Group LLC DNA Technologies
COMMUNIQUÉ DE PRESSE

publié le 14/12/2023 à 14:00, il y a 11 mois 9 jours

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
COMMUNIQUÉ DE PRESSE

publié le 07/12/2023 à 22:05, il y a 11 mois 16 jours

Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results

Publié le 22/11/2024 à 17:45, il y a 1 jour 19 heures

IMMERSION : RFA 2023/2024
Publié le 22/11/2024 à 16:15, il y a 1 jour 21 heures

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Publié le 22/11/2024 à 14:35, il y a 1 jour 22 heures

Communiqué de presse Thales
Publié le 22/11/2024 à 14:35, il y a 1 jour 22 heures

Thales Press release
Publié le 21/11/2024 à 06:58, il y a 3 jours 6 heures

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

Voir tout LES ECHOS COMFI WIRE

Publié le 22/11/2024 à 23:55, il y a 1 jour 13 heures

Boron One Announces Early Warrant Exercise Incentive Program
Publié le 22/11/2024 à 23:30, il y a 1 jour 13 heures

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Publié le 22/11/2024 à 23:05, il y a 1 jour 14 heures

Kidoz Inc. Announces Results of 2024 AGM
Publié le 22/11/2024 à 23:05, il y a 1 jour 14 heures

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Publié le 22/11/2024 à 22:30, il y a 1 jour 14 heures

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

Voir tout ACCESSWIRE

Publié le 22/11/2024 à 18:14, il y a 1 jour 19 heures

Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 22/11/2024 à 18:00, il y a 1 jour 19 heures

Holding(s) in Company
Publié le 22/11/2024 à 17:53, il y a 1 jour 19 heures

Funding Circle Plc: POS-Transaction in Own Shares
Publié le 22/11/2024 à 16:55, il y a 1 jour 20 heures

EQS-Adhoc: Comment on withdrawn non-binding offer
Publié le 22/11/2024 à 16:00, il y a 1 jour 21 heures

Proposed cancellation of admission to trading

Voir tout EQS

News